Skip to content

LIMN

Liminatus Pharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.48
+2.65%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
15.55x
Price / sales
Price / cash flow
-1.18x

Enterprise value

Enterprise value
$3.1M
EV / sales
EV / EBITDA
-0.25x
EV / EBIT
-0.76x
Market cap
$4.7M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026